Topical Losartan for Treating Corneal Fibrosis (Haze): First Clinical Experience

Abstract

Losartan is an inhibitor of transforming growth factor-β signaling. Topical treatment is promising to treat corneal haze formation after corneal injuries, chemical burns, and surgeries. Further clinical studies are needed to optimize losartan dosages and treatment durations. <b>[<i>J Refract Surg</i>. 2022;38(11):741-746.]</b>.